Health care transactions present unique due diligence challenges. The buyer must evaluate the seller's compliance policies and procedures, arrangements with referral sources, patient and payor data, clinical data and compliance with federal and state licensure, certification and reimbursement regulations. The seller will be more attractive to the buyer if due diligence is well-organized, clearly identified and complete. A recent Law360 article written by Deb Daccord and Pamela Kramer provides guidance for buyers as well as sellers on how to navigate this tricky yet vitally important component of a health care transaction.
Karen advises industry clients on regulatory, transactional, operational, and enforcement matters. She has deep experience handling FCA investigations and qui tam litigation for laboratories and diagnostics companies.